Baxalta Incorporated products
A
-
ADVATE (Antihemophilic Factor Recombinant) – Treatment for Hemophilia A with recombinant factor VIII
E
-
ERYTHROPOIETIN (biosimilar) – Therapy for anemia (various formulations under its immuno-oncology and biopharma offerings)
F
-
FEIBA (Anti-Inhibitor Coagulant Complex) – Used in Hemophilia A or B patients who have developed inhibitors against standard factor replacement therapies
G
-
GAMMAGARD LIQUID (intravenous immunoglobulin) – Immunodeficiency therapy for patients needing IgG supplementation
H
-
HYQVIA (Immune Globulin Infusion 10% with Recombinant Hyaluronidase) – Subcutaneous immunoglobulin delivery for primary immunodeficiency patients
O
-
ONCASPAR (pegaspargase) – Pegylated enzyme for treatment of acute lymphoblastic leukemia (ALL), particularly in pediatric cases
R
-
RUCONEST (recombinant human C1 esterase inhibitor) – Management of acute hereditary angioedema (HAE) attacks
No comments:
Post a Comment